2006-03-01
Development of antibodies against the putative proteinase maturation protein A in relation to pneumococcal carriage and otitis media
Publication
Publication
F E M S Immunology and Medical Microbiology , Volume 46 - Issue 2 p. 166- 168
The putative pneumococcal proteinase maturation protein A is a potential pneumococcal vaccine candidate. We examined serum antipneumococcal proteinase maturation protein A antibodies at 6, 12, 18 and 24 months of age, and showed that the age-related development of antipneumococcal proteinase maturation protein A antibodies is associated with pneumococcal contacts. A higher antipneumococcal proteinase maturation protein A antibody concentration at 18 months of age tends to predict for a lower risk of pneumococcal acute otitis media in the following 6 months (relative risk: 0.84, 95% confidence interval: 0.62-1.13).
| Additional Metadata | |
|---|---|
| , , | |
| doi.org/10.1111/j.1574-695X.2005.00012.x, hdl.handle.net/1765/66622 | |
| F E M S Immunology and Medical Microbiology | |
| Organisation | Department of Pediatrics |
|
Bogaert, D., Holmlund, G., Lahdenkari, M., de Groot, R., Kilpi, T., Hermans, P., & Kayhty, H. (2006). Development of antibodies against the putative proteinase maturation protein A in relation to pneumococcal carriage and otitis media. F E M S Immunology and Medical Microbiology, 46(2), 166–168. doi:10.1111/j.1574-695X.2005.00012.x |
|